Pfizer Inc has agreed to pay more than $60 million to settle investigations by the US Securities Exchange Commission and the US Department of Justice in connection with "potentially improper payments"… Continue Reading
We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.
